secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001193125-24-194111
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO grants RSUs to CMO and CSO to promote stability during CEO transition
-------------------------------------------------------------------------------

- On August 1, 2024, REGENXBIO granted 58,386 RSUs to EVP/CMO Stephen Pakola and 58,867 RSUs to EVP/CSO Olivier Danos.
- RSUs vest over two years with one-fourth vesting every six months, subject to continued service.
- Grant aims to retain leadership during a period of CEO transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000119312524194111/0001193125-24-194111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000119312524194111/d862743d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-194111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer